Rheumatic features of sarcoidosis

Area of Science:

• Immunology
• Pulmonology
• Rheumatology

Background:

• Pulmonary sarcoidosis pathogenesis involves alveolar macrophages and T helper 1 cell cytokines, initiating lymphocytic alveolitis.
• A subset of patients exhibits oligoclonal T cell expansion, indicating an antigen-driven immune response in sarcoidosis.
• Sarcoidosis clinical presentations can resemble rheumatic diseases and may co-occur with autoimmune conditions.

Purpose of the Study:

• To elucidate the immunological underpinnings of pulmonary sarcoidosis.
• To investigate the immune response patterns and clinical manifestations of sarcoidosis.
• To understand the course of sarcoidosis, including its relationship with other diseases and treatment outcomes.

Main Methods:

• Analysis of immune cell signaling and cytokine profiles in alveolar macrophages.
• Assessment of T cell receptor repertoire in affected lung tissue.
• Clinical correlation of disease presentation, autoimmune comorbidities, and vitamin D metabolism.
• Evaluation of treatment responses and relapse rates following corticosteroid therapy versus spontaneous remission.

Main Results:

• Immune signals from alveolar macrophages and T helper 1 cytokines are implicated in lymphocytic alveolitis, the initial stage of pulmonary sarcoidosis.
• Evidence suggests an ordered, antigen-driven immune response in a subgroup of sarcoidosis patients due to local T cell expansion.
• Abnormal regulation of 1,25-dihydroxycholecalciferol was observed, with seasonal variations in serum levels.
• Acute sarcoid arthritis typically does not cause joint destruction, but chronic musculoskeletal pain and recurrent arthritis can occur.
• Corticosteroids effectively control sarcoidosis symptoms, yet relapse rates are higher after drug-induced remission compared to spontaneous remission.

Conclusions:

• The pathogenesis of pulmonary sarcoidosis involves complex immune interactions, including macrophage and T cell involvement.
• Sarcoidosis shares clinical and immunological features with rheumatic and autoimmune diseases, necessitating careful differential diagnosis.
• Treatment with corticosteroids is effective for symptom management but is associated with a higher risk of relapse.
• Understanding the immune response and clinical course is crucial for managing sarcoidosis and its potential comorbidities.